Sign inJoin waitlistJoin the waitlist

HW

Howard West

Medical Oncology

Credentials: · · ·

History

Hematology and Medical Oncology
University of Washington-Seattle Campus
1998–2002
Internal Medicine
Brigham and Women's Hospital
1996–1997
Harvard Medical School
1992–1996
University of CambridgeM Phil
1990–1991

Research

Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell…
The Lancet Oncology · 2019 · First of 20 authors · 1,417 citations
Safety and activity of alectinib against systemic disease and brain metastases in patients with crizotinib-resistant ALK-rearranged non-small-cell lung cancer (AF-002JG): results…
The Lancet Oncology · 2014 · 585 citations
Alectinib in ALK-positive, crizotinib-resistant, non-small-cell lung cancer: a single-group, multicentre, phase 2 trial
The Lancet Oncology · 2016 · 534 citations

David Gandara
9 papers · 1 as a fellow
MS
Mark Socinski
7 papers
Ross Camidge
7 papers
Arya Amini
6 papers
RS
Ravi Salgia
5 papers
Scott Gettinger
5 papers
WF
Wilbur Franklin
5 papers
Corey Langer
4 papers
EK
Edward Kim
4 papers
EM
Erminia Massarelli
4 papers
GR
Gregory Riely
4 papers
Karen Reckamp
4 papers